Bladder cancer is the fourth-most common cancer in the United States. It usually affects people age 65 years or older.
Transitional cell carcinoma is the most common type of bladder cancer. Squamous cell carcinoma, adenocarcinoma and small cell carcinoma are the other less common types of bladder cancer.
Why choose the Cancer Therapy & Research Center (CTRC) for bladder cancer?
At the CTRC, a multidisciplinary team led by genitourinary (GU) oncologists, urologists, medical oncologists and radiation oncologists work together in designing ideal treatment for patients. We are the only National Cancer Institute (NCI) designated cancer center in Central and South Texas and have an extensive network of clinical trials to meet patients’ needs.
Our genitourinary oncology care team meets at regularly conducted cancer conferences that include pathologists who specialize in bladder pathology. Your care plan is developed after rapid comprehensive evaluations and discussion. We partner with the National Cancer Institute and other organizations for clinical trial-based treatment options for all patients.
Clinical trials at the CTRC
The CTRC offers care delivered by teams who specialize in all phases of clinical trials. Clinical trials are available to patients of all stages of treatment, from early diagnosis through existing therapies.
As a National Cancer Institute (NCI) designated cancer center, the CTRC also offers experimental treatments and first-in-human clinical trials under special programs for patients.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.